Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Edoardo, Sciatti"'
Autor:
Giulio Balestrieri, Raul Limonta, Enrico Ponti, Anna Merlo, Edoardo Sciatti, Salvatore D’Isa, Mauro Gori, Gavino Casu, Cristina Giannattasio, Michele Senni, Emilia D’Elia
Publikováno v:
Cardiac Failure Review, Vol 10, Iss , Pp - (2024)
Heart failure with preserved ejection fraction (HFpEF) is a clinical syndrome characterised by the presence of diastolic dysfunction and elevated left ventricular filling pressure, in the setting of a left ventricular ejection fraction of at least 50
Externí odkaz:
https://doaj.org/article/241a376307484ebe87b1d808514d07c0
Autor:
Carlo Di Mario, Stefano Genovese, Gaetano A. Lanza, Edoardo Mannucci, Giancarlo Marenzi, Edoardo Sciatti, Dario Pitocco, the Expert Panel Group
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-10 (2022)
Abstract Background Continuous glucose monitoring (CGM) shows in more detail the glycaemic pattern of diabetic subjects and provides several new parameters (“glucometrics”) to assess patients’ glycaemia and consensually guide treatment. A bette
Externí odkaz:
https://doaj.org/article/dce65477b2d2402c97826b0a5966b44e
Autor:
Inge Dierickx, Robert-Jan Alers, Rossana Orabona, Edoardo Sciatti, Marc Spaanderman, Federico Prefumo, Chahinda Ghossein-Doha
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
Externí odkaz:
https://doaj.org/article/c89804708c1c47438620959da450a940
Publikováno v:
Cardiology Plus, Vol 7, Iss 1, Pp 20-28 (2022)
Abstract. Heart failure with reduced ejection fraction (HFrEF) is a common disease requiring multi-drug therapy. Moreover, it is associated with a poor prognosis, with increasing prevalence in the community. In the last decade, two major drug classes
Externí odkaz:
https://doaj.org/article/cbc95f47feac4fddad4f56982626bb56
Autor:
Nicola Bernardi, Edoardo Sciatti, Edoardo Pancaldi, Fabio Alghisi, Andrea Drera, Raffaele Falco, Enrico Vizzardi
Publikováno v:
Monaldi Archives for Chest Disease (2022)
Coeliac disease (CD) is an autoimmune condition with a high prevalence among general population and multisystemic involvement: a more complex scene than a merely gastrointestinal disease. Therefore, an early diagnosis and treatment with a gluten-free
Externí odkaz:
https://doaj.org/article/db0e47621ef24d1c8e16f6f9228a6534
Publikováno v:
Cardiac Failure Review, Vol 8, Iss , Pp - (2022)
Heart failure (HF) with preserved left ventricular ejection fraction is a common disease with a poor prognosis and rising prevalence in the community. The current paradigm of treatment includes symptomatic therapy, such as diuretics, and risk factor
Externí odkaz:
https://doaj.org/article/3733938e4b7b43128f22d973d83e4c4b
Autor:
Liala Moschetti, Silvia Piantoni, Enrico Vizzardi, Edoardo Sciatti, Mauro Riccardi, Franco Franceschini, Ilaria Cavazzana
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
This review describes the complex interplay between inflammation, vasculopathy and fibrosis that involve the heart and peripheral small vessels, leading to endothelial stiffness, vascular damage, and early aging in patients with systemic lupus erythe
Externí odkaz:
https://doaj.org/article/69945cd33a6f4a7dafbb944073ae8d22
Autor:
Nicola Mumoli, MD, Claudia Amellone, MD, Gianfranco Antonelli, MD, Giuseppe Augello, MD, Cosima Cloro, MD, Alberto D’Alleva, MD, Leonardo Di Ascenzo, MD, PhD, Egidio Imbalzano, MD, Renato Masala, MD, Graziano Riccioni, MD, Emanuele Romeo, MD, Luca Rossi, MD, Giosuè Santoro, MD, Edoardo Sciatti, MD, Antonio Tondo, MD, Elisabetta Toso, MD, Elio Venturini, MD, Enrico Vizzardi, MD, Giosuè Mascioli, MD
Publikováno v:
CJC Open, Vol 2, Iss 6, Pp 641-651 (2020)
Background: In recent years, direct-acting oral anticoagulants (DOACs) have entered clinical practice for stroke prevention in non-valvular atrial fibrillation or prevention and treatment of venous thromboembolism. However, remaining uncertainty rega
Externí odkaz:
https://doaj.org/article/34d00093d7204fd4bbd1e8903ba5874a
Autor:
Edoardo Sciatti, Emilia D’Elia, Giulio Balestrieri, Salvatore D’Isa, Attilio Iacovoni, Michele Senni
Publikováno v:
European Heart Journal Supplements. 25:C301-C305
Hyperkalaemia is a life-threatening condition leading to significant morbidity and mortality. It is common in heart failure (HF) patients due to the disease itself, which often co-exists with chronic kidney disease and diabetes mellitus, the fluctuat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab96405e903725cc4f88d375578e231f
https://doi.org/10.1093/eurheartjsupp/suad053
https://doi.org/10.1093/eurheartjsupp/suad053
Publikováno v:
European Heart Journal Supplements. 25:B140-B143
The 2021 European Society of Cardiology guidelines for the diagnosis and treatment of acute and chronic heart failure (HF) have abandoned the sequential approach for optimal drug therapy and propose four drug classes (enzyme inhibitors conversion age
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b84ee8fbb3086dc6f31b44765c58886d
https://doi.org/10.1093/eurheartjsupp/suad099
https://doi.org/10.1093/eurheartjsupp/suad099